Home / Share Price Target / Concordbio
Concord Biotech Share Price Target 2024, 2025, 2026 to 2039 With Charts
Concord Biotech Limited | |||
 | Symbol: CONCORDBIO | ||
| Price: ₹1,991.19 | |||
| Exchange: NSE | |||
| Healthcare -> Biotechnology | |||
Show Table of Contents
Table of Contents
- 1: Concord Biotech Brief Company Overview
- 1.1: Concord Biotech Limited: A Pioneer in Biopharmaceuticals
- 1.1.1: Diverse Product Range
- 1.1.2: Commitment to Innovation
- 1.1.3: Strong Industry Reputation
- 1.2: Concord Biotech Financial Performance
- 1.2.1: Is Concord Biotech A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Concord Biotech Share Price Target For 2024
- 2.1.1: Concord Biotech Share Price Target Table For 2024
- 2.1.2: Summary: Concord Biotech Share Price Prediction For 2024
- 2.2: Concord Biotech Share Price Target For 2025
- 2.2.1: Concord Biotech Share Price Target Table For 2025
- 2.2.2: Summary: Concord Biotech Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Concord Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Concord Biotech Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Concord Biotech Past Performance
Concord Biotech Brief Company Overview
Concord Biotech Limited: A Pioneer in Biopharmaceuticals
Established in 1984, Concord Biotech Limited is a reputable biopharma company based in India. With a global market presence, they specialize in research and development, manufacturing, marketing, and sale of pharmaceuticals.
Diverse Product Range
- Fermentation-based active pharmaceutical ingredients
- Immunosuppressants (tacrolimus, mycophenolate mofetil, etc.)
- Oncology (temsirolimus, everolimus, etc.)
- Anti-bacterial (mupirocin, vancomycin hydrochloride, etc.)
- Anti-fungal (anidulafungin, caspofungi, etc.)
Commitment to Innovation
Concord Biotech is dedicated to providing cutting-edge pharmaceutical solutions. Their contract research and manufacturing services leverage advanced fermentation and semi-synthesis technologies.
Strong Industry Reputation
The company has established a strong reputation in the industry for its quality products and reliable services. Their commitment to innovation and customer satisfaction has earned them recognition as a leading player in the biopharma sector.
Concord Biotech Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 19,364.5 Crore | Market valuation of Concord Biotech's shares. |
| Revenue (TTM) | 1,037.91 Crore | Total revenue generated by Concord Biotech over the past twelve months. |
| Net Income (TTM) | +313.2 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 31.55% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 30.17% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +10.8% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +9.4% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 0.63 | Company's total debt divided by total shareholder equity. |
| Total Debt | 9.73 Crore | Sum of Concord Biotech's current & long-term financial obligations. |
| Total Cash | 281.66 Crore | Total amount of liquid funds available to Concord Biotech. |
Is Concord Biotech A Good Buy For Long Term?
Concord Biotech, a mid-cap stock with a market capitalization of ₹19,853.5 crore, shows strong financial health. Its ₹327.92 crore net profit (30.2% margin) on ₹1,085.74 crore revenue in the last 12 months (TTM) is impressive, especially considering its low debt of ₹3.42 crore and substantial cash balance of ₹283.74 crore (Q2 2024-25). While the past three-year and five-year returns are 0%, the recent performance is excellent (12-month return: 65.21%). Considering this positive trajectory and robust financials, Concord Biotech appears to be a good buy for the long term.
To predict the Concord Biotech's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Concord Biotech Share Price Target For 2024
The line chart displays the monthly closing prices of Concord Biotech with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Concord Biotech shares in 2024, see the table below.
Concord Biotech Share Price Target Table For 2024
| Concord Biotech's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 2065.18 (+3.71%) | Custom Fibonacci Extension Lvl 64.9% |
| 2024 Target 2 | 2043.44 (+2.62%) | Price Action: 18 Oct 2024 High |
| 2024 Target 1 | 2018.09 (+1.35%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 1991.19 | Concord Biotech's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 1982.93 (-0.42%) | Price Action: Chart |
| Stop Loss 2 | 1962.00 (-1.47%) | Fibonacci Retracement Level 50% |
| Stop Loss 3 | 1938.00 (-2.68%) | Price Action: 19 Nov 2024 High |
Summary: Concord Biotech Share Price Prediction For 2024
In summary, Concord Biotech has surged by ₹519.39, achieving a notable +35.29% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Concord Biotech for 2024 predicts an additional rise of 1.35% to 3.71% by the end of 2024 with three potential targets T1: 2018.09, T2: 2043.44, T3: 2065.18. Stop Loss at SL1: 1982.93, SL2: 1962.00, SL3: 1938.00.
Concord Biotech has a 52-week high of ₹2664.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1212.05, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Concord Biotech.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Concord Biotech Share Price Target For 2025
The line chart displays the monthly closing prices of Concord Biotech with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Concord Biotech shares in 2025, see the table below.
Concord Biotech Share Price Target Table For 2025
| Concord Biotech's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 2677.78 (+34.48%) | Price Action: Chart |
| 2025 Target 2 | 2627.85 (+31.97%) | Price Action: Chart |
| 2025 Target 1 | 2601.83 (+30.66%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1991.19 | Concord Biotech's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 1848.00 (-7.2%) | Price Action: 28 Oct 2024 High |
| Stop Loss 2 | 1824.05 (-8.4%) | Price Action: 07 Nov 2024 Low |
| Stop Loss 3 | 1803.80 (-9.42%) | Price Action: 24 Oct 2024 Low |
Summary: Concord Biotech Share Price Prediction For 2025
In summary, Concord Biotech has surged by ₹519.39, achieving a notable +35.29% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Concord Biotech for 2025 predicts an additional rise of 30.66% to 34.48% by the end of 2025 with three potential targets T1: 2601.83, T2: 2627.85, T3: 2677.78. Stop Loss at SL1: 1848.00, SL2: 1824.05, SL3: 1803.80.
Concord Biotech has a All-Time high of ₹2664.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1212.05, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Concord Biotech, we have created a specific page for that check here: Concord Biotech Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Concord Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Concord Biotech share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.3% over the next 15 years.
For complete year by year Concord Biotech long term share price target from 2024, 2025 to 2039 check the below table.
Concord Biotech Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Concord Biotech Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,991.19 | [Current Price] |
| 2024 | ₹2,021.21 | 1.5% |
| 2025 | ₹2,658.83 | 31.54% |
| 2026 | ₹3,302.28 | 24.2% |
| 2027 | ₹3,948.99 | 19.58% |
| 2028 | ₹4,571.78 | 15.77% |
| 2029 | ₹5,218.74 | 14.15% |
| 2030 | ₹5,854.1 | 12.17% |
| 2031 | ₹6,501.8 | 11.06% |
| 2032 | ₹7,154.04 | 10.03% |
| 2033 | ₹7,764.1 | 8.52% |
| 2034 | ₹8,416.27 | 8.39% |
| 2035 | ₹9,049.36 | 7.52% |
| 2036 | ₹9,701.32 | 7.2% |
| 2037 | ₹10,359.09 | 6.78% |
| 2038 | ₹10,956.43 | 5.76% |
| 2039 | ₹11,613.37 | 5.99% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Concord Biotech Past Performance
- In 2023, Concord Biotech opening price was ₹900.05
- As of Thu 21 Nov 2024 the price stands at ₹1,991.19.
- This represents a Compound Annual Growth Rate (CAGR) of 48.74%.
- In 1 year, an investment of 10,000 would have become ₹22,123.1.
As we wrap up, we hope you like our study on Concord Biotech share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Concord Biotech Share Price History
- Concord Biotech Price Target Tomorrow
- Concord Biotech Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
